| scholarly article | Q13442814 |
| P50 | author | James Fung | Q41791161 |
| Ching-Lung Lai | Q56885069 | ||
| Man-Fung Yuen | Q59187364 | ||
| Seto WK | Q79434476 | ||
| Pok Yeung | Q114725848 | ||
| P2093 | author name string | Danny Ka-Ho Wong | |
| P2860 | cites work | Different types of ground glass hepatocytes in chronic hepatitis B virus infection contain specific pre-S mutants that may induce endoplasmic reticulum stress | Q24672497 |
| MEGA3: Integrated software for Molecular Evolutionary Genetics Analysis and sequence alignment | Q27860726 | ||
| The PreS2 activators of the hepatitis B virus: activators of tumour promoter pathways | Q33534991 | ||
| Infection process of the hepatitis B virus depends on the presence of a defined sequence in the pre-S1 domain | Q33653137 | ||
| Hepatitis B virus pre-S deletion mutations are a risk factor for hepatocellular carcinoma: a matched nested case-control study | Q33918324 | ||
| High prevalence of hepatitis B virus pre-s mutant in countries where it is endemic and its relationship with genotype and chronicity | Q34952562 | ||
| Activation of hepatitis B virus S promoter by the viral large surface protein via induction of stress in the endoplasmic reticulum. | Q35895318 | ||
| The role of envelope proteins in hepatitis B virus assembly | Q37393563 | ||
| Hepatitis B virus pre-S2 mutant upregulates cyclin A expression and induces nodular proliferation of hepatocytes. | Q40455477 | ||
| Prevalence and significance of hepatitis B virus (HBV) pre-S mutants in serum and liver at different replicative stages of chronic HBV infection | Q40836209 | ||
| Hepatitis B virus immunopathology | Q40951387 | ||
| Combined mutations in pre-s/surface and core promoter/precore regions of hepatitis B virus increase the risk of hepatocellular carcinoma: a case-control study | Q42443551 | ||
| Two control elements in the hepatitis B virus S-promoter are important for full promoter activity mediated by CCAAT-binding factor | Q42469688 | ||
| High prevalence and mapping of pre-S deletion in hepatitis B virus carriers with progressive liver diseases | Q42493404 | ||
| Properties of hepatitis B virus pre-S1 deletion mutants | Q42602807 | ||
| Mutations in preS genes of genotype C hepatitis B virus in patients with chronic hepatitis B and hepatocellular carcinoma | Q43996842 | ||
| Hepatitis B virus pre-S2 mutant surface antigen induces degradation of cyclin-dependent kinase inhibitor p27Kip1 through c-Jun activation domain-binding protein 1. | Q44421847 | ||
| Molecular and clinical characteristics of hepatitis B virus in Korea | Q45375652 | ||
| The prevalence of hepatitis B virus preS deletions occurring naturally in Korean patients infected chronically with genotype C. | Q45395244 | ||
| Association of pre-S deletion mutant of hepatitis B virus with risk of hepatocellular carcinoma | Q45402316 | ||
| Risk for hepatocellular carcinoma with respect to hepatitis B virus genotypes B/C, specific mutations of enhancer II/core promoter/precore regions and HBV DNA levels | Q45404348 | ||
| Clinical significance of pre-S mutations in patients with genotype C hepatitis B virus infection | Q45407122 | ||
| Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage | Q45631058 | ||
| Influence of hepatitis B virus genotypes on the development of preS deletions and advanced liver disease | Q45723052 | ||
| Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B | Q58235862 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Hepatitis B virus | Q6844 |
| hepatitis B | Q6853 | ||
| hepatocellular carcinoma | Q1148337 | ||
| P304 | page(s) | 646-654 | |
| P577 | publication date | 2011-01-12 | |
| P1433 | published in | Journal of Infectious Diseases | Q4051141 |
| P1476 | title | Association of hepatitis B virus pre-S deletions with the development of hepatocellular carcinoma in chronic hepatitis B | |
| P478 | volume | 203 |
| Q40105542 | A putative hepatitis B virus splice variant associated with chronic hepatitis and liver cirrhosis |
| Q28744484 | A ubiquitin independent degradation pathway utilized by a hepatitis B virus envelope protein to limit antigen presentation |
| Q35541314 | Associations between pre-S deletion mutation of hepatitis B virus and risk of hepatocellular carcinoma in the Asian population: a meta-analysis |
| Q38165139 | Broad spectrum of hepatocyte inclusions in humans, animals, and experimental models |
| Q36018516 | Characterization of Novel Hepatitis B Virus PreS/S-Gene Mutations in a Patient with Occult Hepatitis B Virus Infection |
| Q59349588 | Chronic hepatitis B virus infection |
| Q42496260 | Clinical features and prognosis of hepatocellular carcinoma with respect to pre-S deletion and basal core promoter mutations of hepatitis B virus Genotype C2. |
| Q26773676 | Clinical significance of hepatitis B surface antigen mutants |
| Q42436025 | Combined core promoter mutations and pre-S deletion of HBV may not increase the risk of HCC: a geographical epidemiological study in Guangxi, China |
| Q90005462 | Comparison of pre-S1/S2 variations of hepatitis B virus between asymptomatic carriers and cirrhotic/hepatocellular carcinoma-affected individuals |
| Q39536967 | DeF-GPU: Efficient and effective deletions finding in hepatitis B viral genomic DNA using a GPU architecture |
| Q40269219 | Deep sequencing analysis of quasispecies in the HBV pre-S region and its association with hepatocellular carcinoma. |
| Q37267283 | Different pre-S deletion patterns and their association with hepatitis B virus genotypes |
| Q34306010 | Diverse modes of genomic alteration in hepatocellular carcinoma |
| Q35793292 | Evolutionary Changes of Hepatitis B Virus Pre-S Mutations Prior to Development of Hepatocellular Carcinoma |
| Q40443053 | Expression of a hepatitis B virus pre-S2 deletion mutant in the liver results in hepatomegaly and hepatocellular carcinoma in mice. |
| Q42507635 | Fine mapping of hepatitis B virus pre-S deletion and its association with hepatocellular carcinoma. |
| Q35881253 | Functional analysis of hepatitis B virus pre-s deletion variants associated with hepatocellular carcinoma |
| Q26772348 | Genetic variation of hepatitis B virus and its significance for pathogenesis |
| Q38408847 | Genotypes and viral variants in chronic hepatitis B: A review of epidemiology and clinical relevance |
| Q28484102 | Genotyping and molecular characterization of hepatitis B virus from human immunodeficiency virus-infected individuals in southern Africa |
| Q39428108 | HCC-Associated Single Nucleotide Variants and Deletions Identified Using Genome-Wide High Throughput Analysis of HBV. |
| Q40893329 | Hepatitis B virus full-length genomic mutations and quasispecies in hepatocellular carcinoma |
| Q42251541 | Hepatitis B virus infection in clustering of infection in families with unfavorable prognoses in northwest China |
| Q52584501 | Hepatitis B virus pre-S/S variants in liver diseases. |
| Q34451816 | Hepatitis B virus pre-S2 start codon mutations in Indonesian liver disease patients. |
| Q99239119 | Hepatitis B virus preS2Δ38-55 variants: A newly identified risk factor for hepatocellular carcinoma |
| Q40258634 | Hepatitis B virus sequencing and liver fibrosis evaluation in HIV/HBV co-infected Nigerians |
| Q38174263 | Impact of HBV therapy on the incidence of hepatocellular carcinoma |
| Q45353165 | Lack of association between hepatitis B virus pre-S mutations and recurrence after surgical resection in hepatocellular carcinoma |
| Q36139170 | Molecular characterization of hepatitis B virus among chronic hepatitis B patients from Pointe Noire, Republic of Congo |
| Q26823512 | Molecular mechanism of hepatitis B virus-induced hepatocarcinogenesis |
| Q38536404 | Molecular mechanisms underlying HBsAg negativity in occult HBV infection |
| Q36691039 | Mutual antagonism between hepatitis B viral mRNA and host microRNA let-7. |
| Q64226390 | Naturally Occurring Hepatitis B Virus Mutations Leading to Endoplasmic Reticulum Stress and Their Contribution to the Progression of Hepatocellular Carcinoma |
| Q34303069 | Novel approach to identifying the hepatitis B virus pre-S deletions associated with hepatocellular carcinoma |
| Q38179533 | Occult hepatitis B virus infection and hepatocellular carcinoma: a systematic review |
| Q45338178 | One small SNP for receptor virus entry, one giant leap for hepatitis B? |
| Q42221265 | Pre-S mutations of hepatitis B virus affect genome replication and expression of surface antigens |
| Q44137160 | Pre-s mutation is a significant risk factor for hepatocellular carcinoma development: a long-term retrospective cohort study |
| Q34295883 | Precore mutation of hepatitis B virus may contribute to hepatocellular carcinoma risk: evidence from an updated meta-analysis |
| Q38027061 | Prevention of hepatitis B virus-related hepatocellular carcinoma with antiviral therapy |
| Q36227142 | Quantitative evaluation of hepatitis B virus mutations and hepatocellular carcinoma risk: a meta-analysis of prospective studies |
| Q54264663 | Relative Abundance of Integrant-Derived Viral RNAs in Infected Tissues Harvested from Chronic Hepatitis B Virus Carriers. |
| Q28550305 | Risk Factors and Post-Resection Independent Predictive Score for the Recurrence of Hepatitis B-Related Hepatocellular Carcinoma |
| Q35085724 | S gene mutants occurrence among hepatitis B carriers in malaysia |
| Q33661054 | Significance of viral status on occurrence of hepatitis B-related hepatocellular carcinoma |
| Q40442201 | Stop codons in the hepatitis B surface proteins are enriched during antiviral therapy and are associated with host cell apoptosis |
| Q34785355 | The Influence of Hepatitis B Viral Load and Pre-S Deletion Mutations on Post-Operative Recurrence of Hepatocellular Carcinoma and the Tertiary Preventive Effects by Anti-Viral Therapy. |
| Q95936549 | The evolution and clinical impact of hepatitis B virus genome diversity |
| Q59349430 | The preS deletion of hepatitis B virus (HBV) is associated with liver fibrosis progression in patients with chronic HBV infection |
| Q36269684 | Transposon mouse models to elucidate the genetic mechanisms of hepatitis B viral induced hepatocellular carcinoma. |
| Q37957297 | Virus-triggered autophagy in viral hepatitis - possible novel strategies for drug development |
| Q34526468 | Whole genome HBV deletion profiles and the accumulation of preS deletion mutant during antiviral treatment |
Search more.